Provided by Tiger Trade Technology Pte. Ltd.

Stryker

317.40
-6.4000-1.98%
Post-market: 317.460.0600+0.02%19:45 EDT
Volume:2.14M
Turnover:685.75M
Market Cap:121.38B
PE:32.89
High:331.50
Open:329.83
Low:316.85
Close:323.80
52wk High:396.86
52wk Low:281.00
Shares:382.42M
Float Shares:353.30M
Volume Ratio:1.05
T/O Rate:0.61%
Dividend:3.48
Dividend Rate:1.10%
EPS(TTM):9.65
EPS(LYR):8.40
ROE:16.51%
ROA:8.16%
PB:5.06
PE(LYR):37.79

Loading ...

Movement Alert|Stryker Rises 4.67% in Regular Trading, Trading at $330.83

Market Focus
·
Jun 27

Stryker Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 25

Stryker Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 23

Stryker Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 18

Stryker Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 16

SpyGlass Pharma appoints Shannon Treviño as general counsel

Reuters
·
Jun 15

Stryker price target lowered to $380 from $450 at BofA

TIPRANKS
·
Jun 12

Stryker Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 12

Stryker Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 11

Stryker Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 09

If AI Healthcare Wins Big These Three Stocks Could Matter

Simply Wall St.
·
Jun 08

Stryker Is Maintained at Outperform by Leerink Partners

Dow Jones
·
Jun 05

Leerink Partners Adjusts Price Target on Stryker to $407 From $410, Maintains Outperform Rating

MT Newswires Live
·
Jun 05

Stryker Corp. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 05

Stryker - Launches Tpx Hd Power Tool for Orthopaedic Procedures

THOMSON REUTERS
·
Jun 02

Stryker Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 02

Fractyl Health names Mike Zumdahl SVP of market access, commercial strategy

Reuters
·
Jun 01

Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib

GlobeNewswire
·
Jun 01

Don't Ignore The Insider Selling In Stryker

Simply Wall St.
·
May 30

Stryker director Ronda E. Stryker disposes of USD 96.9 million in common shares

Reuters
·
May 29